In Other News

• New Generation of Long-Acting Immunotherapeutic Antivirals Aim to Prevent COVID-19/Flu ‘Twindemics’

• FDA Publishes Comparative Performance Data for COVID-19 Molecular Diagnostic Tests

• Researchers Find Possible Pathway to New Antiviral Drugs to Fight All Three Coronaviruses

• Eli Lilly’s Neutralizing Antibody Therapy for COVID-19 Reduces Hospitalization Rates in Phase 2 Clinical Trial

• Pfizer’s COVID-19 Vaccine Shows Mild-To-Moderate Side Effects in Phase 3 Clinical Trial

• Self-Swab COVID-19 Collection Kit Receives FDA EUA for Use by CLIA-Certified Laboratories

• First-in-Class Rapid Diagnostic Test Measures COVID-19 Neutralizing Antibodies in Plasma and Serum

• Roche Granted FDA Emergency Use Authorization for Cobas SARS-CoV-2 & Influenza A/B Test

• Scientists Developing Decoy Molecule as Therapeutic Against SARS-CoV-2 That Could Be Inhaled Directly Into the Lungs

• Fujifilm Sonosite to Investigate Role of Point-of-Care Ultrasound in COVID-19 Patients Through Clinical Research

• CT Scans of COVID-19 “Long-Haulers” Reveal Damaged Lungs Begin Repairing Themselves After 12 Weeks

• COVID-19 Face Mask Containing Laser-Induced Graphene Deactivates Coronavirus Under Sunlight

• COVID-19 Mathematical Model Indicates Flu Season May Cause 2.5-Fold Increase in Coronavirus Transmission

• Scientists Retraining Coronavirus-Specific T Cells to Target Cancer Cells in Novel Immune-Oncology Approach

• Scientists Use Cloud-Based Supercomputing and AI to Develop COVID-19 Treatments and Vaccine Models

• Artificial Intelligence and Machine Learning Could Enhance Scientific Peer Review of COVID-19 Papers

• Protective Immunity Against SARS-CoV-2 Short-Lived as Seasonal Coronavirus Can Reinfect People Every Year

• World's First Commercially Available Saliva-Based COVID-19 Test Detects Coronavirus in 3-10 Minutes

• Siemens Collaborates with CDC to Develop Process for Standardizing SARS-CoV-2 Assays

• Oxford University to Evaluate Regeneron's Investigational Anti-Viral Antibody Cocktail in Hospitalized COVID-19 Patients

• Universal Mask-Wearing Could Increase Population-Wide COVID-19 Immunity, Say Researchers

• Stem Cells Offer Hope of Treatment for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)

• Merck Begins Human Trials of COVID-19 Vaccine Candidate; You Can’t Rush Science, Warns CEO